Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid

Summary

Bullous pemphigoid is the most common type of bullous skin disease and is clinically characterized by clear-tense bullae, which result in post-bullous cutaneous erosions, altering the skin barrier. The treatment of this pathology consists of the application of high doses of topical corticosteroids (clobetasol propionate) for a prolonged period of at least 6 months. The main objective of this study is to demonstrate a change in bone mineral density at 6 months after initiation of treatment, in subjects with bullous pemphigoid and treated with topical corticosteroid.

Timeline

Start

2020-12-11

Primary completion

2025-10-22

Completion

2026-03-04

Drugs

Indications